Skip to content
10-Q

Quarterly Report

Auspex Pharmaceuticals, Inc.

0001564590-14-005340

← back to feed
Filed
Nov 10, 2014 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 1, 2014 27.58M sh
Capex Q3 2014 · Sep 30, 2014 $217K
Capex Q3 2014 · Sep 30, 2013 $14K
Long Term Debt Q3 2014 · Sep 30, 2014 $13.39M
Long Term Debt Q3 2014 · Dec 31, 2013 $14.42M
Short Term Debt Q3 2014 · Sep 30, 2014 $1.16M
Cash And Equivalents Q3 2014 · Sep 30, 2014 $89.69M
Cash And Equivalents Q3 2014 · Dec 31, 2013 $36.65M
Cash And Equivalents Q3 2014 · Sep 30, 2013 $11.37M
Cash And Equivalents Q3 2014 · Dec 31, 2012 $4.28M
Stockholders Equity Q3 2014 · Sep 30, 2014 $139.47M
Stockholders Equity Q3 2014 · Dec 31, 2013 −$64.94M
Current Liabilities Q3 2014 · Sep 30, 2014 $9.02M
Current Liabilities Q3 2014 · Dec 31, 2013 $3.49M
Total Liabilities Q3 2014 · Sep 30, 2014 $22.56M
Total Liabilities Q3 2014 · Dec 31, 2013 $21.96M
Current Assets Q3 2014 · Sep 30, 2014 $165.93M
Current Assets Q3 2014 · Dec 31, 2013 $36.89M
Total Assets Q3 2014 · Sep 30, 2014 $166.3M
Total Assets Q3 2014 · Dec 31, 2013 $38.87M
Sga Expense Q3 2014 · Sep 30, 2014 $3.11M
Sga Expense Q3 2014 · Sep 30, 2014 $8.69M
Sga Expense Q3 2014 · Sep 30, 2013 $476K
Sga Expense Q3 2014 · Sep 30, 2013 $1.76M
Rd Expense Q3 2014 · Sep 30, 2014 $10.8M
Rd Expense Q3 2014 · Sep 30, 2014 $21.37M
Rd Expense Q3 2014 · Sep 30, 2013 $2.36M
Rd Expense Q3 2014 · Sep 30, 2013 $6.52M
Net Income Q3 2014 · Sep 30, 2014 −$19.04M
Net Income Q3 2014 · Sep 30, 2014 −$39.55M
Net Income Q3 2014 · Sep 30, 2013 −$2.85M
Net Income Q3 2014 · Sep 30, 2013 −$8.04M
Operating Income Q3 2014 · Sep 30, 2014 −$13.91M
Operating Income Q3 2014 · Sep 30, 2014 −$30.05M
Operating Income Q3 2014 · Sep 30, 2013 −$2.84M
Operating Income Q3 2014 · Sep 30, 2013 −$8.28M